Source: Annual Congress 2008 - Airway cell biology and immunology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Barta, T. Kullmann, I. Horváth, B. Antus (Budapest, Hungary). Cytokine pattern in the exhaled breath of patients with planocellular lung carcinomas. Eur Respir J 2008; 32: Suppl. 52, 3595

Member's Comments

No comment yet.

Related content which might interest you: Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Detection of ProGRP and NSE in exhaled breath condensate (EBC) of patients with SCLC and NSCLc Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Exhaled MMP-9 in lung cancer Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Structures of an exhaled breath condensate in lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 525s Year: 2005 Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Influence of salivary nitrite on levels in exhaled breath condensate in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Attempt of detection of CYFRA 21-1 in exhaled breath condensate by patients with NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006 Correlation of FENO with nitrites and nitrates in exhaled breath condensate in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007